Last modified
12/25/2018 - 02:01

Prevalence of Benzodiazepine Use 12.6 Percent in the United States

General, 12. 6 percent regarding U. S. grown ups record past-year benzodiazepine use, together with misuse accounting for 18. 2 pct of total use, according to a new study published online Dec. 17 in Psychiatric Providers.

Donovan T. Maust, Meters. D., through the University associated with Michigan in Ann Arbor, and colleagues conducted a new cross-sectional analysis of information from the 2015 plus 2016 National Survey upon Drug Use and Wellness limited to grownups older ≥18 years (86, 186 participants) and respondents credit reporting benzodiazepine use (10, 290 participants). The authors analyzed the prevalence of benzodiazepine use, including variation by age.

Prevalence of Benzodiazepine Use 12.6 Percent in the United States

The researchers identified that 30. 6 , 000, 000 grownups (12. 6 percent) reported past-year benzodiazepine use: 10. 4 and a couple of. 2 % as prescribed and misuse, respectively. Total, misuse accounted for 18. 2 pct of employ. The highest recommended employ was seen for grownups ages 50 to 64 years (12. 9 percent). Misuse was highest for anyone ages 18 to more than 20 years (5. 2 percent) and lowest for those old ≥65 years (0. 6th percent).

There was a strong correlation for wrong use and abuse of or dependence on prescription opioids or stimulants with benzodiazepine misuse.
The most frequent type of misuse was misuse without a prescribed, with the most frequent source being a friend or relative.


"Although clinicians should be conscious in the potential for benzodiazepine misuse among patients together with any level of substance use, findings indicated that prescribed opioid and stimulant employ disorders were most strongly associated with benzodiazepine wrong use, " the authors compose.

Send inquiry online For more product information and prices

(Pharmaceutical Ingredients Manufacturer & Supplier & Exporter.)

After sending the online inquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email. —— Green Stone Swiss

Email: sales@raw-pharmaceutical-materials.com
Tel: +86 592 5365887
WhatsApp: +86 189 6515 7632
Send inquiry online: